CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	9 Months Ended
	Apr. 30, 2022	Apr. 30, 2021
Cash flows from operating activities:
Net income	$ 856,456	$ 429,548
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	95,206	82,533
Amortization of intangible assets	117,288	87,110
Amortization of debt issuance costs	8,457	12,825
Deferred income tax benefit	(18,830)	(4,499)
(Gain) loss on disposition of property, plant and equipment	833	(296)
Stock-based compensation expense	22,736	21,424
Changes in assets and liabilities:
Accounts receivable	(256,180)	(175,635)
Inventories, net	(338,852)	(632,506)
Prepaid income taxes, expenses and other	(4,578)	(28,280)
Accounts payable	78,897	341,535
Accrued liabilities	92,693	32,581
Long-term liabilities and other	(16,577)	8,733
Net cash provided by operating activities	637,549	175,073
Cash flows from investing activities:
Purchases of property, plant and equipment	(170,702)	(81,162)
Proceeds from dispositions of property, plant and equipment	823	1,742
Business acquisitions, net of cash acquired	(781,967)	(310,938)
Other	(20,000)	9,330
Net cash used in investing activities	(971,846)	(381,028)
Cash flows from financing activities:
Borrowings on revolving asset-based credit facilities	660,088	225,676
Payments on revolving asset-based credit facilities	(559,035)	(114,836)
Proceeds from issuance of senior unsecured notes	500,000	0
Payments on term-loan credit facilities	(124,565)	(59,700)
Payments on other debt	(7,842)	(9,711)
Payments of debt issuance costs	(8,445)	0
Regular cash dividends paid	(71,496)	(68,100)
Payments on finance lease obligations	(801)	(492)
Purchases of treasury shares	(98,321)	0
Payments related to vesting of stock-based awards	(18,011)	(8,317)
Short-term financial obligations and other, net	(21,120)	(7,323)
Net cash provided by (used in) financing activities	250,452	(42,803)
Effect of exchange rate changes on cash and cash equivalents and restricted cash	(32,882)	4,857
Net decrease in cash and cash equivalents and restricted cash	(116,727)	(243,901)
Cash and cash equivalents and restricted cash, beginning of period	448,706	541,363
Cash and cash equivalents and restricted cash, end of period	331,979	297,462
Cash and cash equivalents and restricted cash, total	331,979	297,462
Less: restricted cash	2,682	2,900
Cash and cash equivalents	329,297	294,562
Supplemental cash flow information:
Income taxes paid	270,063	172,397
Interest paid	59,454	62,048
Non-cash investing and financing transactions:
Capital expenditures in accounts payable	$ 7,914	$ 3,497